TY - JOUR
KW - buprenorphine
KW - cannabinoid
KW - cannabis
KW - Methadone
KW - opioid agonist treatment
KW - opioid use disorder
AU - Maria Eugenia Socias
AU - Evan Wood
AU - Stephanie Lake
AU - Seonaid Nolan
AU - Nadia Fairbairn
AU - Kanna Hayashi
AU - Hennady P. Shulha
AU - Seagle Liu
AU - Thomas Kerr
AU - M-J Milloy
A1 - 
AD - British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
BT - Addiction (Abingdon, England)
C5 - Healthcare Disparities; Opioids & Substance Use
CY - England
DO - 10.1111/add.14398
JF - Addiction (Abingdon, England)
LA - eng
M1 - Journal Article
PB - Society for the Study of Addiction
PP - England
PY - 2018
SN - 1360-0443; 0965-2140
T1 - High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis
T2 - Addiction (Abingdon, England)
TI - High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 30238568
U3 - 10.1111/add.14398
VO - 1360-0443; 0965-2140
Y1 - 2018
Y2 - Sep 20
ER -